Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Jaya Padmanabhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2019-5135; OpenAlex author ID A5086059416. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 4

  1. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDA… Last author DOI 10.3390/ijms20102423↗
  2. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling. Last author DOI 10.18632/oncotarget.5933↗
  3. The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression. First author DOI 10.3390/cancers7030845↗
  4. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells. First author DOI 10.1074/jbc.m113.459255↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Srikumar Chellappan · 3 shared papers, 2015–2019 · strength 0.25
  2. Shengyu Yang · 2 shared papers, 2015–2019 · strength 0.17
  3. Neha Kabra Woods · 2 shared papers, 2013–2015 · strength 0.14
  4. Marwa Alhothali · 1 shared paper, 2019 · strength 0.11
  5. Courtney M. Schaal · 1 shared paper, 2015 · strength 0.08
  6. Domenico Coppola · 1 shared paper, 2015 · strength 0.06
  7. Jose Trevino · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.